FPX Biosensors for Live Cell Imaging Published It is always a pleasure to collaborate with our neighbors at University of Alberta! As the Campbell Lab so succinctly summarized this work: “First there was FRET, now there is FPX!” Many thanks to Yidan Ding,...
Drug Discovery News Biotek Scientific Director likes Montana Molecular’s live cell assays: “These sensors can be used for the simultaneous detection of all these second messengers. That is something that is really unique and really powerful, specifically for...
$1.1 million investment from the National Institutes of Health advances next generation tools for drug discovery in living cells. Montana Molecular, a privately-held company developing next generation tools for drug discovery in living cells, has been awarded a Phase...
DAG sensor and μ-opioid receptor desensitization Early adopters of Montana Molecular’s DAG sensor at The Vollum Institute published new results in the British Journal of Pharmacology. This study made good use of our Upward DAG sensor for diacylglycerol to...
Montana Molecular’s DAG sensor helped unravel the molecular mechanisms of TRPC6 cation channel activity which could lead to new treatments for TRPC6-associated diseases that affect cardiovascular and kidney dysfunction such as vasospasm and...
BacMam technology is evolving and transduction efficiencies have improved substantially since many of these pioneering papers were published. This body of work provides a summary of what has been accomplished and a starting point for assay optimization in your cell...
